Galectin (Gal)-1 and Gal-3 facilitate the proliferation of hepatic stellate cells and play an important role in liver fibrosis [5], in which Gal-1 is a promising molecular target for the development of therapeutic tools to treat fibrosis in different chronic diseases [6]. Here, LGALS3 is linked to Hepatic fibrosis.